Aria Pharmaceuticals

Aria Pharmaceuticals is a clinical-stage biopharmaceutical company that applies artificial intelligence and machine learning to drug discovery, using a computational platform to identify and advance small-molecule therapeutic candidates for complex, inflammatory, and immunological diseases. Backed by Andreessen Horowitz (a16z), Aria operates as a therapeutics developer rather than a software or API provider. It was added to the API Evangelist network as a portfolio-company profile; an enrichment pass found no public developer portal, API documentation, OpenAPI definition, SDKs, or other programmatic developer surface for the company at this time.

Aria Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Drug Discovery, Artificial Intelligence, and Biotechnology.

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyPharmaceuticalsDrug DiscoveryArtificial IntelligenceBiotechnologyHealthcareLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/aria-pharmaceuticals: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Aria Pharmaceuticals Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: aria-pharmaceuticals
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/aria-pharmaceuticals.png
name: Aria Pharmaceuticals
description: Aria Pharmaceuticals is a clinical-stage biopharmaceutical company that applies artificial intelligence and machine
  learning to drug discovery, using a computational platform to identify and advance small-molecule therapeutic candidates
  for complex, inflammatory, and immunological diseases. Backed by Andreessen Horowitz (a16z), Aria operates as a therapeutics
  developer rather than a software or API provider. It was added to the API Evangelist network as a portfolio-company profile;
  an enrichment pass found no public developer portal, API documentation, OpenAPI definition, SDKs, or other programmatic
  developer surface for the company at this time.
url: https://raw.githubusercontent.com/api-evangelist/aria-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Pharmaceuticals
- Drug Discovery
- Artificial Intelligence
- Biotechnology
- Healthcare
- Life Sciences
apis: []
common:
- type: Website
  url: https://ariapharmaceuticals.com
- type: DomainSecurity
  url: security/aria-pharmaceuticals-domain-security.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence